Not applicableEnded earlyNCT01954576What this trial is testingNovoTTF Therapy in Treating Patients With Recurrent Glioblastoma MultiformeWho this might be right forGlioblastomaBrain Neoplasms University of Florida 21
Testing effectiveness (Phase 2)Study completedNCT00453310What this trial is testingSunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to TreatmentWho this might be right forExtragonadal Germ Cell TumorOvarian CancerTeratoma+1 more Memorial Sloan Kettering Cancer Center 10
Early research (Phase 1)Ended earlyNCT00492440What this trial is testingInterleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) Cytheris SA 9
Early research (Phase 1)WithdrawnNCT00458744What this trial is testingTalotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to TreatmentWho this might be right forBrain and Central Nervous System TumorsLeukemiaLymphoma+1 more Children's Oncology Group
Testing effectiveness (Phase 2)Study completedNCT01239316What this trial is testingVismodegib in Treating Younger Patients With Recurrent or Refractory MedulloblastomaWho this might be right forRecurrent Childhood Medulloblastoma National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT04526899What this trial is testingInvestigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of TreatmentWho this might be right forMelanoma Stage IIIMelanoma Stage IVUnresectable Melanoma BioNTech SE 184
Testing effectiveness (Phase 2)Ended earlyNCT01836549What this trial is testingImetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic EpendymomaAstrocytoma, Grade II+6 more Pediatric Brain Tumor Consortium 43
Testing effectiveness (Phase 2)Ended earlyNCT05551117What this trial is testingVobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsWho this might be right forCastration-Resistant Prostatic CancerAndrogen-Independent Prostatic CancerAndrogen-Insensitive Prostatic Cancer+14 more MacroGenics 192
Testing effectiveness (Phase 2)Ended earlyNCT00014443What this trial is testingTopotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Rush University Medical Center 5
Early research (Phase 1)Study completedNCT01222780What this trial is testingTo Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory CancerWho this might be right forSarcomaNeuroblastomaWilms Tumor+3 more Acrotech Biopharma Inc. 22
Early research (Phase 1)Temporarily pausedNCT06355908What this trial is testingIL13Rα2 CAR-T for Patients With r/r GliomaWho this might be right forGlioma Yang Zhang 30
Not applicableAvailableNCT01590680What this trial is testingExpanded Access Protocol Using 131I-MIBGWho this might be right forNeuroblastomaPheochromocytomaParaganglioma Jubilant DraxImage Inc.
Early research (Phase 1)Ended earlyNCT07121829What this trial is testingTovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid TumorsWho this might be right forMelanomaSolid TumorPilocytic Astrocytoma+7 more Day One Biopharmaceuticals, Inc. 44
Early research (Phase 1)Ended earlyNCT05429502What this trial is testingStudy of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid TumorsWho this might be right forNeuroblastoma Novartis Pharmaceuticals 12
Testing effectiveness (Phase 2)Study completedNCT03760081What this trial is testingAssess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell TumorsWho this might be right forIncurable Platinum Refractory Germ Cell TumorsTumors Astellas Pharma Global Development, Inc. 19
Testing effectiveness (Phase 2)Study completedNCT02116777What this trial is testingTalazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent MalignanciesWho this might be right forAdult Solid NeoplasmChildhood Solid NeoplasmRecurrent Childhood Central Nervous System Neoplasm+3 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT02596828What this trial is testingProspective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade PineoblastomaWho this might be right forPineoblastoma University of Regensburg 4
Early research (Phase 1)Study completedNCT00206388What this trial is testingZoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone InvolvementWho this might be right forNEUROBLASTOMA Baylor College of Medicine 21
Not applicableStudy completedNCT01850888What this trial is testingMIBG for Refractory Neuroblastoma and PheochromocytomaWho this might be right forRelapsed NeuroblastomaMetastatic Pheochromocytoma Masonic Cancer Center, University of Minnesota 15
Testing effectiveness (Phase 2)Looking for participantsNCT06803875What this trial is testingStudy of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk NeuroblastomaWho this might be right forRelapsed NeuroblastomaRefractory NeuroblastomaHigh-risk Neuroblastoma Roberto Chiarle 42